You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
司太立(603520.SH)擬以募集資金向子公司海神製藥增資1.32億元
格隆匯 08-18 19:40

格隆匯 8 月 18日丨司太立(603520.SH)公佈,公司於2020年8月18日召開的第四屆董事會第四次會議審議通過《關於以募集資金向全資子公司浙江台州海神製藥有限公司增資的議案》,同意以公司非公開發行股票部分募集資金向全資子公司浙江台州海神製藥有限公司(“海神製藥”)增資用以實施其募投項目。結合募投項目當前實際情況,公司此次擬向海神製藥增資1.32億元。

此次通過直接向募投項目實施主體海神製藥增資的方式實施募投項目,可在保持募集資金合規使用的前提下,簡化募集資金使用流程,提高募集資金使用效率,且不會改變募投項目的投向和項目基本建設內容。此次增資後,海神製藥註冊資本由1億元增加至2.32億元,仍為公司全資子公司。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account